Canadian Alcohol and Drug Use Monitoring Survey

Detailed Tables

Table 1: Main 2012 CADUMS indicators by sex and by age - Drugs
  Overall Males Females p<0.05
- sex
15-24 25+ p<0.05
- age
Sample size= 11,090 4,386 6,704   687 10,403  
Cannabis use
Cannabis - lifetime 41.5
[39.8-43.3]
47.9
[45.1-50.7]
35.5
[33.4-37.7]
Significant difference between males and females 34.8
[29.5-40.1]
42.8
[41.0-44.6]
Significant difference between youth age 15-24 and adults age 25+
Cannabis - past-year 10.2
[9.1-11.4]
13.7
[11.8-15.6]
7.0
[5.7-8.2]
Significant difference between males and females 20.3
[15.9-24.6]
8.4
[7.3-9.5]
Significant difference between youth age 15-24 and adults age 25+
Age of initiation (years) 18.6
[18.4-18.9]
18.5
[18.1-18.8]
18.8
[18.5-19.1]
  16.1
[15.8-16.4]
19.0
[18.7-19.3]
Significant difference between youth age 15-24 and adults age 25+
Illicit drug use past year
Cocaine/Crack 1.1Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.6]
1.5Estimate qualified due to high sampling variability; interpret with caution
[0.7-2.3]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.1]
 
Speed Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Methamphetamine/Crystal meth Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Hallucinogens 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.3]
1.5Estimate qualified due to high sampling variability; interpret with caution
[0.9-2.2]
Estimate suppressed due to high sampling variability   3.9Estimate qualified due to high sampling variability; interpret with caution
[2.0-5.8]
0.4Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.6]
Significant difference between youth age 15-24 and adults age 25+
Hallucinogens (including salvia) 1.1Estimate qualified due to high sampling variability; interpret with caution
[0.7-1.5]
1.8Estimate qualified due to high sampling variability; interpret with caution
[1.1-2.6]
Estimate suppressed due to high sampling variability   4.8Estimate qualified due to high sampling variability; interpret with caution
[2.6-6.9]
0.4Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.6]
Significant difference between youth age 15-24 and adults age 25+
Ecstasy 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.0]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Salvia Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Heroin Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 10.6
[9.4-11.8]
14.3
[12.3-16.3]
7.1
[5.8-8.3]
Significant difference between males and females 21.3
[16.8-25.8]
8.6
[7.5-9.7]
Significant difference between youth age 15-24 and adults age 25+
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 2.0
[1.4-2.5]
2.9Estimate qualified due to high sampling variability; interpret with caution
[1.9-3.9]
1.0Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.6]
Significant difference between males and females 6.3Estimate qualified due to high sampling variability; interpret with caution
[3.6-8.9]
1.2Estimate qualified due to high sampling variability; interpret with caution
[0.7-1.6]
Significant difference between youth age 15-24 and adults age 25+
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 10.6
[9.4-11.8]
14.3
[12.3-16.3]
7.1
[5.8-8.4]
Significant difference between males and females 21.3
[16.8-25.8]
8.6
[7.5-9.7]
Significant difference between youth age 15-24 and adults age 25+
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 2.0
[1.5-2.6]
3.1Estimate qualified due to high sampling variability; interpret with caution
[2.1-4.1]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.6]
Significant difference between males and females 6.5Estimate qualified due to high sampling variability; interpret with caution
[3.9-9.2]
1.2Estimate qualified due to high sampling variability; interpret with caution
[0.8-1.6]
Significant difference between youth age 15-24 and adults age 25+
Any drugc 11.3
[10.1-12.5]
15.2
[13.1-17.2]
7.7
[6.4-9.0]
Significant difference between males and females 22.2
[17.6-26.7]
9.3
[8.1-10.4]
Significant difference between youth age 15-24 and adults age 25+
Lifetime illicit drug use
Cocaine/Crack 7.3
[6.3-8.3]
9.9
[8.2-11.7]
4.7
[3.8-5.7]
Significant difference between males and females 5.5Estimate qualified due to high sampling variability; interpret with caution
[2.8-8.2]
7.6
[6.5-8.7]
 
Speed 4.1
[3.3-4.9]
5.7
[4.3-7.1]
2.5
[1.8-3.2]
Significant difference between males and females 2.4Estimate qualified due to high sampling variability; interpret with caution
[0.9-4.0]
4.4
[3.5-5.3]
Significant difference between youth age 15-24 and adults age 25+
Methamphetamine/Crystal meth 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-0.9]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.3]
0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.7]
  Estimate suppressed due to high sampling variability 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.0]
 
Hallucinogens 12.5
[11.3-13.6]
16.6
[14.5-18.6]
8.6
[7.4-9.8]
Significant difference between males and females 8.7Estimate qualified due to high sampling variability; interpret with caution
[5.7-11.8]
13.2
[11.9-14.4]
Significant difference between youth age 15-24 and adults age 25+
Hallucinogens (including salvia) 12.7
[11.5-13.9]
16.9
[14.8-19.0]
8.7
[7.5-9.9]
Significant difference between males and females 9.4Estimate qualified due to high sampling variability; interpret with caution
[6.3-12.5]
13.3
[12.0-14.6]
Significant difference between youth age 15-24 and adults age 25+
Ecstasy 4.4
[3.6-5.2]
5.6
[4.2-7.1]
3.2
[2.4-4.1]
Significant difference between males and females 7.9Estimate qualified due to high sampling variability; interpret with caution
[5.0-10.9]
3.7
[2.9-4.6]
Significant difference between youth age 15-24 and adults age 25+
Salvia 1.8
[1.2-2.3]
2.9Estimate qualified due to high sampling variability; interpret with caution
[1.9-3.9]
0.7Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.2]
Significant difference between males and females 6.5Estimate qualified due to high sampling variability; interpret with caution
[3.7-9.3]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.2]
Significant difference between youth age 15-24 and adults age 25+
Heroin 0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.7]
0.7Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.1]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.5Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.8]
 
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 42.3
[40.6-44.1]
48.8
[46.0-51.6]
36.2
[34.1-38.4]
Significant difference between males and females 35.2
[29.9-40.5]
43.7
[41.8-45.5]
Significant difference between youth age 15-24 and adults age 25+
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 15.4
[14.1-16.7]
19.7
[17.6-21.9]
11.4
[10.0-12.7]
Significant difference between males and females 12.2
[8.8-15.6]
16.0
[14.7-17.4]
Significant difference between youth age 15-24 and adults age 25+
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 42.3
[40.6-44.1]
48.8
[46.0-51.6]
36.2
[34.1-38.4]
Significant difference between males and females 35.3
[29.9-40.6]
43.7
[41.8-45.5]
Significant difference between youth age 15-24 and adults age 25+
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 15.6
[14.3-16.9]
20.0
[17.8-22.2]
11.4
[10.0-12.8]
Significant difference between males and females 12.5
[9.1-16.0]
16.2
[14.8-17.6]
 
Any drugc 43.2
[41.4-45.0]
49.8
[46.9-52.6]
37.0
[34.9-39.2]
Significant difference between males and females 36.9
[31.4-42.3]
44.4
[42.6-46.3]
Significant difference between youth age 15-24 and adults age 25+
Pharmaceutical use past year
Pain Relievers 16.9
[15.5-18.3]
15.5
[13.4-17.6]
18.2
[16.5-19.9]
  18.0
[13.5-22.6]
16.7
[15.3-18.0]
 
Pain relievers to get high 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.2-1.0]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Pain relievers to get high - among users 3.4Estimate qualified due to high sampling variability; interpret with caution
[1.2-5.6]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Abuse of pain relievers (includes to get high) 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.3]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.8]
0.7Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.2]
  Estimate suppressed due to high sampling variability 0.5Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.7]
 
Abuse of pain relievers (includes to get high) - among users 5.2Estimate qualified due to high sampling variability; interpret with caution
[2.9-7.6]
6.9Estimate qualified due to high sampling variability; interpret with caution
[2.7-11.2]
3.9Estimate qualified due to high sampling variability; interpret with caution
[1.5-6.4]
  Estimate suppressed due to high sampling variability 3.1Estimate qualified due to high sampling variability; interpret with caution
[1.7-4.4]
 
Stimulants 1.5Estimate qualified due to high sampling variability; interpret with caution
[1.0-2.0]
1.9Estimate qualified due to high sampling variability; interpret with caution
[1.0-2.8]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.7]
  4.9Estimate qualified due to high sampling variability; interpret with caution
[2.2-7.6]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.3]
Significant difference between youth age 15-24 and adults age 25+
Stimulants to get high Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Stimulants to get high - among users Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Abuse of stimulants 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.9]
0.6Estimate qualified due to high sampling variability; interpret with caution
[0.2-1.0]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Abuse of stimulants  (includes to get high) - among users 40.1Estimate qualified due to high sampling variability; interpret with caution
[22.8-57.4]
32.5Estimate qualified due to high sampling variability; interpret with caution
[12.4-52.6]
52.2Estimate qualified due to high sampling variability; interpret with caution
[26.9-77.4]
  44.0Estimate qualified due to high sampling variability; interpret with caution
[17.0-71.0]
36.1Estimate qualified due to high sampling variability; interpret with caution
[13.1-59.1]
 
Sedatives 10.2
[9.2-11.3]
7.5
[5.9-9.0]
12.8
[11.4-14.2]
Significant difference between males and females 7.5Estimate qualified due to high sampling variability; interpret with caution
[4.4-10.6]
10.7
[9.6-11.8]
 
Sedatives to get high Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Sedatives to get high - among users Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Any pharmaceutical 24.1
[22.5-25.6]
21.3
[18.8-23.7]
26.7
[24.7-28.6]
Significant difference between males and females 24.7
[19.6-29.8]
23.9
[22.4-25.5]
 
Any pharmaceutical to get high 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.3]
1.2Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.9]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.4Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.7]
 
Any pharmaceutical to get high - among users 3.6Estimate qualified due to high sampling variability; interpret with caution
[1.8-5.4]
5.6Estimate qualified due to high sampling variability; interpret with caution
[2.2-9.1]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 1.8Estimate qualified due to high sampling variability; interpret with caution
[0.7-2.9]
 
Abuse of any pharmaceutical (includes to get high) 1.5Estimate qualified due to high sampling variability; interpret with caution
[1.0-2.0]
1.6Estimate qualified due to high sampling variability; interpret with caution
[0.9-2.4]
1.4Estimate qualified due to high sampling variability; interpret with caution
[0.7-2.1]
  4.9Estimate qualified due to high sampling variability; interpret with caution
[2.2-7.5]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.2]
Significant difference between youth age 15-24 and adults age 25+
Abuse of any pharmaceutical (includes to get high) - among users 6.3Estimate qualified due to high sampling variability; interpret with caution
[4.2-8.4]
7.8Estimate qualified due to high sampling variability; interpret with caution
[4.2-11.4]
5.2Estimate qualified due to high sampling variability; interpret with caution
[2.6-7.7]
  19.8Estimate qualified due to high sampling variability; interpret with caution
[10.0-29.5]
3.7Estimate qualified due to high sampling variability; interpret with caution
[2.1-5.2]
Significant difference between youth age 15-24 and adults age 25+
Drug related harms in past yearTable #t1_fnb1 footnote 1
Any drug harm to self - total population 2.0Estimate qualified due to high sampling variability; interpret with caution
[1.4-2.7]
3.0Estimate qualified due to high sampling variability; interpret with caution
[1.8-4.3]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.7]
Significant difference between males and females 5.5Estimate qualified due to high sampling variability; interpret with caution
[2.9-8.2]
1.4Estimate qualified due to high sampling variability; interpret with caution
[0.8-2.0]
Significant difference between youth age 15-24 and adults age 25+
Any drug harm to self among users any 5 drugsTable 1 footnote 2 38.7Estimate qualified due to high sampling variability; interpret with caution
[24.1-53.2]
41.7Estimate qualified due to high sampling variability; interpret with caution
[24.5-58.9]
Estimate suppressed due to high sampling variability   43.0Estimate qualified due to high sampling variability; interpret with caution
[21.1-64.9]
34.3Estimate qualified due to high sampling variability; interpret with caution
[15.8-52.7]
 
Any drug harm to self among users any drugTable 1 footnote 3 16.6
[11.3-21.9]
18.3Estimate qualified due to high sampling variability; interpret with caution
[11.2-25.5]
13.3Estimate qualified due to high sampling variability; interpret with caution
[6.2-20.4]
  24.1Estimate qualified due to high sampling variability; interpret with caution
[13.5-34.7]
13.3Estimate qualified due to high sampling variability; interpret with caution
[7.2-19.3]
 
  • [95% Confidence Interval]
  • Sample size
  • Estimate qualified due to high sampling variability; interpret with caution
  • Estimate suppressed due to high sampling variability
  • Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high
  • Significant difference between males and females
  • Significant difference between youth age 15-24 and adults age 25+
Table 1 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to table 1 footnote 1 referrer

Table 1 footnote 2

Among current user any 5 drugs (cocaine, speed, hallucinogens including salvia, ecstasy, heroin)

Return to table 1 footnote 2 referrer

Table 1 footnote 3

Among current users any drug (cannabis, cocaine, meth/crystal meth, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, abuse of pain killers, abuse of stimulants, sedatives to get high)

Return to table 1 footnote 3 referrer

Table 2: Main 2012 CADUMS indicators by province - Drugs
  Canada NL PE NS NB QC ON MB SK AB BC
= 11,090 1,008 1,008 1,009 1,009 1,008 1,011 1,009 1,010 1,009 2,009
Cannabis use
Cannabis - lifetime 41.5 38.7 40.9 42.4 36.4 40.6 39.4 38.5 42.5 44.3 48.7
Cannabis - past-year 10.2 11.0 10.6 12.1 8.5 9.0 9.1 13.2 10.2 11.4 13.8
Illicit drug use past year
Cocaine/Crack 1.1 1.4
Speed
Methamphetamine/Crystal meth
Hallucinogens 0.9
Ecstasy 0.6
Salvia
Heroin
Any 6 drugs (hallucinogens excl. salvia) 10.6 11.0 10.6 12.2 8.6 9.5 9.6 13.4 10.6 11.6 13.9
Any 5 drugs (hallucinogens excl. salvia) 2.0 2.5 2.9 2.1 2.7
Any drug 11.3 11.1 10.8 12.9 9.2 10.0 10.4 14.7 11.1 12.1 14.9
Lifetime illicit drug use
Cocaine/Crack 7.3 6.6 4.4 5.0 3.4 6.3 7.5 6.3 6.9 7.3 9.9
Speed 4.1 2.6 2.4 2.7 5.2 4.3 2.9 1.9 3.1 3.7
Methamphetamine/Crystal meth 0.7 1.0
Hallucinogens 12.5 8.2 10.2 10.7 6.9 8.9 12.8 12.4 14.2 14.9 17.4
Ecstasy 4.4 4.9 3.6 3.4 2.2 3.7 4.4 3.4 4.1 4.8 6.3
Salvia 1.8 3.1 1.9 4.1 2.0 2.1
Heroin 0.5 0.8
Any 6 drugs (hallucinogens excl. salvia) 42.3 39.0 41.3 43.0 37.3 41.1 40.3 39.7 42.9 45.4 49.5
Any 5 drugs (hallucinogens excl. salvia) 15.4 11.0 12.3 12.9 10.1 13.3 14.7 15.2 15.6 17.6 21.6
Any drug 43.2 39.4 41.8 44.0 38.7 41.9 41.1 41.1 43.9 46.4 50.6
Drug related harms in past yearTable 2 footnote 1
Any drug harm to self - total populationTable #t2_fnb2 footnote 2 2.0 1.5 2.5 2.2 3.1 2.1
  • Sample size
  • Estimate qualified due to high sampling variability; interpret with caution
  • Estimate suppressed due to high sampling variability
  • Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high

Table 2 footnotes

Table 2 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems

Return to table 2 footnote 1 referrer

Table 2 footnote 2

Asked of all users of any drug (cannabis, cocaine, meth/crystal meth, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, abuse of pain killers, abuse of stimulants, sedatives to get high) ; presented among total population

Return to table 2 footnote 2 referrer

Table 3: Prevalence of drug use and harms, total population, CAS 2004, CADUMS 2008 - 2012
  2004
Overall
2008
Overall
2009
Overall
2010
Overall
2011
Overall
2012
Overall
= 13,909 16,640 13,082 13,615 10,076 11,090
Cannabis use
Cannabis - lifetime 44.5
[43.0-46.0]
43.9
[42.4-45.4]
42.4
[40.8-44.1]
41.5
[39.9-43.0]
39.4
[37.6-41.2]
41.5
[39.8-43.3]
Cannabis - past-year 14.1
[13.1-15.1]
11.4
[10.4-12.5]
10.6
[9.5-11.8]
10.7
[9.8-11.7]
9.1
[8.0-10.2]
10.2
[9.1-11.4]
Cannabis - Age of initiation (years) 18.8
[18.5-19.1]
18.4
[18.2-18.7]
18.7
[18.4-19.0]
18.4
[18.1-18.7]
18.8
[18.5-19.1]
18.6
[18.4-18.9]
Illicit drug use past year
Cocaine/Crack 1.9
[1.5-2.3]
1.6
[1.2-2.1]
1.2
[0.8-1.8]
0.7
[0.5-0.9]
0.9
[0.5-1.3]
1.1
[0.6-1.6]
Speed 0.8
[0.6-1.1]
1.1
[0.8-1.5]
0.4
[0.2-0.8]
0.5
[0.3-0.6]
0.5
[0.2-0.7]
Hallucinogens(excluding salvia) 0.7
[0.5-0.9]
0.7
[0.5-1.1]
0.9
[0.6-1.1]
0.6
[0.3-0.9]
0.9
[0.6-1.3]
Hallucinogens (including salvia) 2.1
[1.7-2.8]
0.9
[0.6-1.4]
1.1
[0.8-1.3]
0.9
[0.5-1.2]
1.1
[0.7-1.5]
Ecstasy 1.1
[0.8-1.5]
1.4
[1.0-1.9]
0.9
[0.6-1.4]
0.7
[0.6-0.9]
0.7
[0.4-1.0]
0.6
[0.3-1.0]
Any 6 drugs (hallucinogens excl. salvia) 14.5
[13.5-15.6]
11.0
[9.9-12.3]
11.0
[10.0-12.0]
9.4
[8.3-10.5]
10.6
[9.4-11.8]
Any 5 drugs (hallucinogens excl. salvia) 3.0
[2.6-3.6]
2.0
[1.5-2.6]
1.8
[1.5-2.1]
1.7
[1.2-2.2]
2.0
[1.4-2.5]
Any 6 drugs (hallucinogens incl. salvia) 12.1
[11.1-13.2]
11.1
[10.0-12.3]
11.1
[10.1-12.1]
9.4
[8.3-10.5]
10.6
[9.4-11.8]
Any 5 drugs (hallucinogens incl. salvia) 3.9
[3.3-4.7]
2.1
[1.6-2.8]
2.0
[1.6-2.3]
1.9
[1.3-2.4]
2.0
[1.5-2.6]
Pharmaceutical use past year
Pain Relievers 21.6
[20.4-22.9]
19.2
[18.0-20.5]
20.6
[19.3-21.8]
16.7
[15.4-18.0]
16.9
[15.5-18.3]
Pain relievers to get high 0.3
[0.2-0.6]
0.4
[0.2-0.9]
0.2
[0.1-0.4]
0.6
[0.2-1.0]
Pain relievers to get high - among users 1.5
[0.9-2.6]
2.3
[1.1-4.5]
1.1
[0.4-1.7]
3.4
[1.2-5.6]
Abuse of pain relievers (includes to get high) 0.9
[0.5-1.3]
Abuse of pain relievers (includes to get high) - among users 5.2
[2.9-7.6]
Stimulants 1.1
[0.8-1.5]
1.0
[0.7-1.4]
1.0
[0.8-1.3]
0.9
[0.6-1.2]
1.5
[1.0-2.0]
Stimulants to get high 0.3
[0.1-0.6]
0.1
[0.0-0.3]
Stimulants to get high - among users 25.5
[12.3-45.5]
9.4
[2.6-28.6]
Abuse of stimulants 0.6
[0.3-0.9]
Abuse of stimulants  (includes to get high) - among users 27.4
[10.5-44.3]
40.1
[22.8-57.4]
Sedatives 10.7
[9.8-11.6]
9.1
[8.2-10.0]
8.7
[7.8-9.6]
9.1
[8.1-10.0]
10.2
[9.2-11.3]
Sedatives to get high 0.2
[0.0-0.5]
0.2
[0.1-0.4]
0.05
[0.02-0.08]
Sedatives to get high - among users 1.4
[0.5-4.3]
1.7
[0.6-4.7]
0.5
[0.2-0.9]
Any pharmaceutical 28.4
[27.0-29.7]
25.0
[23.7-26.4]
26.0
[24.6-27.3]
22.9
[21.5-24.4]
24.1
[22.5-25.6]
Any pharmaceutical to get high 0.6
[0.3-0.9]
0.6
[0.3-1.0]
0.3
[0.1-0.4]
0.3
[0.1-0.5]
0.9
[0.4-1.3]
Any pharmaceutical to get high - among users 2.0
[1.2-3.2]
2.3
[1.2-4.1]
1.0
[0.5-1.6]
1.5
[0.6-2.4]
3.6
[1.8-5.4]
Abuse of any pharmaceutical (includes to get high) 0.7
[0.4-1.1]
1.5
[1.0-2.0]
Abuse of any pharmaceutical (includes to get high) - among users 3.2
[1.6-4.8]
6.3
[4.2-8.4]
Drug related harms in past yearTable 3 footnote 1
Any drug harm to self - total population 2.8
[2.4-3.3]
2.7
[2.1-3.3]
2.1
[1.7-2.6]
1.8
[1.3-2.3]
2.0
[1.4-2.7]
Any drug harm to self among users any 5 drugsTable 3 footnote 2 36.7
[29.1-45.1]
37.5
[28.9-47.0]
36.4
[27.7-45.0]
41.6
[26.9-56.3]
38.7
[24.1-53.2]
Any drug harm to self among users any drugTable 3 footnote 3 17.5
[14.8-20.5]
21.7
[17.6-26.3]
17.0
[13.5-20.5]
17.6
[13.0-22.1]
16.6
[11.3-21.9]
  • [95% Confidence Interval]
  • Sample size
  • Estimate qualified due to high sampling variability; interpret with caution
  • Estimate suppressed due to high sampling variability
  • No comparable estimates.
  • Indicates that the difference between 2008 and 2004 is statistically significant.
  • Indicates that the difference between 2009 and 2004 is statistically significant.
  • Indicates that the difference between 2010 and 2004 is statistically significant.
  • Indicates that the difference between 2011 and 2004 is statistically significant.
  • Indicates that the difference between 2012 and 2004 is statistically significant.
  • Indicates that the difference between 2009 and 2008 is statistically significant.
  • Indicates that the difference between 2011 and 2010 is statistically significant.
  • Indicates that the difference between 2012 and 2011 is statistically significant.
  • Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cocaine/crack, speed, ecstasy, hallucinogens, heroin
Table 3 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to table 3 footnote 1 referrer

Table 3 footnote 2

Among past year users any 5 drugs (cocaine, speed, hallucinogens, ecstasy, heroin). CADUMS 2010-2012: hallucinogens include salvia.

Return to table 3 footnote 2 referrer

Table 3 footnote 3

Among past year users CAS (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, steroids), CADUMS 2008 (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2010 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2011-2012 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, abuse of pain killers, abuse of stimulants, sedatives to get high)

Return to table 3 footnote 3 referrer

Table 4: Prevalence of drug use and harms, by age group, CAS 2004 and CADUMS 2008 - 2012
  CAS 2004
15-24
CADUMS 2008
15-24
CADUMS 2009
15-24
CADUMS 2010
15-24
CADUMS 2011
15-24
CADUMS 2012
15-24
CAS 2004
25+
CADUMS 2008
25+
CADUMS 2009
25+
CADUMS 2010
25+
CADUMS 2011
25+
CADUMS 2012
25+
= 2,085 1,443 955 3,989 671 687 11,519 15,197 12,079 9,626 9,405 10,403
Cannabis use
Cannabis - lifetime 61.4 52.9 42.9 41.7 34.0 34.8 41.8 42.1 42.3 41.4 40.4 42.8
Cannabis - past year 37.0 32.7 26.3 25.1 21.6
20.3 10.0 7.3 7.6 7.9 6.7
8.4
Age of initiation (Years) 15.6 15.5 15.6 15.7 15.6
16.1 19.7 19.2 19.3 18.9 19.3 19.0
Illicit drug use past year
Cocaine/Crack 5.5 5.9 3.0 2.7 1.2 0.8 0.9 0.3 0.7 0.7
Speed 3.9 3.7 1.9 0.2 0.6
Hallucinogens (excl. salvia) 3.5 3.2 3.4 2.0 3.9 0.1 0.3 0.4 0.4
Hallucinogens (incl. salvia) 10.2 4.4 4.6 3.4 4.8 0.6 0.3 0.4 0.4
Ecstasy 4.4 6.5 3.6 3.8 2.6 0.5 0.4 0.4
Any 6 drugs (hallucinogens excl. salvia) 37.9 27.3 25.9 21.9 21.3 10.3 7.9 8.1 6.9 8.6
Any 5 drugs (hallucinogens excl. salvia) 11.3 5.5 7.0 4.8 6.3 1.5 1.3 0.8 1.1 1.2
Any 6 drugs (hallucinogens incl. salvia) 34.0 27.5 26.1 21.9 21.3 7.9 7.9 8.2 6.9 8.6
Any 5 drugs (hallucinogens incl. salvia) 15.4 6.3 7.9 5.8 6.5 1.7 1.3 0.8 1.1 1.2
Pharmaceutical use past year
Pain Relievers 17.7 14.6 18.2 14.3 18.0 22.4 20.2 21.0 17.1 16.7
Pain Relievers to get high 0.9 1.2 0.2 0.3
Pain Relievers to get high - among users 4.9 8.5 1.0 1.4
Abuse of pain relievers (includes to get high) 0.2 0.5
Abuse of pain relievers (includes to get high) - among users 1.3 3.1
Stimulants 3.1 2.7 3.2 2.4 4.9 0.7 0.6 0.6 0.6 0.9
Stimulants to get high 1.2 0.1
Stimulants to get high - among users 38.3 14.7
Abuse of stimulants (includes to get high)
Abuse of stimulants (includes to get high) - among users 44.0 36.1
Sedatives 5.5 4.0 3.5 4.0 7.5 11.7 10.1 9.7 10.1 10.7
Sedative to get high 0.8
Sedatives to get high - among users 14.4
Any pharmaceutical 22.3 18.2 22.1 17.6 24.7 29.5 26.3 26.7 23.9 23.9
Any pharmaceutical to get high 2.1 1.7 0.8 0.3 0.3 0.2 0.4
Any pharmaceutical to get high - among users 9.4 9.5 3.8 0.9 1.3 0.9 1.8
Abuse of any pharmaceutical (includes to get high) 4.9 0.5 0.9
Abuse of any pharmaceutical (includes to get high) - among users 19.8 1.9 3.7
Drug related harms in past yearTable 4 footnote 1
Any drug harm to self - of total population 9.5 10.8 6.9 5.8 5.5 1.6 1.1 1.2 1.1 1.4
Any drug harm to self among users any 5 drugsTable 4 footnote 2 42.1 42.0 41.6 45.0 43.0 28.7 29.5 26.6 38.1 34.3
Any drug harm to self among users any drugTable 4 footnote 3 24.0 31.5 24.7 23.1 24.1 12.7 13.5 12.2 14.2 13.3
  • Sample size
  • Estimate qualified due to high sampling variability; interpret with caution
  • Estimate suppressed due to high sampling variability
  • No comparable estimates.
  • Indicates that the difference between 2008 and 2004 is statistically significant.
  • Indicates that the difference between 2009 and 2004 is statistically significant.
  • Indicates that the difference between 2010 and 2004 is statistically significant.
  • Indicates that the difference between 2011 and 2004 is statistically significant.
  • Indicates that the difference between 2012 and 2004 is statistically significant.
  • Indicates that the difference between 2009 and 2008 is statistically significant.
  • Indicates that the difference between 2011 and 2010 is statistically significant.
  • Indicates that the difference between 2012 and 2011 is statistically significant.
  • Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cocaine/crack, speed, ecstasy, hallucinogens, heroin
Table 4 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to Table 4 footnote 1 referrer

Table 4 footnote 2

Among past year users any 5 drugs (cocaine, speed, hallucinogens, ecstasy, heroin). CADUMS 2010-2012: hallucinogens include salvia.

Return to Table 4 footnote 2 referrer

Table 4 footnote 3

Among past year users CAS (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, steroids), CADUMS 2008 (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2010 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2011-2012 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, abuse of pain killers, abuse of stimulants, sedatives to get high).

Return to Table 4 footnote 3 referrer

Table 5: Prevalence of drug use and harms, by sex, CAS 2004, CADUMS 2008 - 2012
  CAS 2004 Males CADUMS 2008 Males CADUMS 2009 Males CADUMS 2010 Males CADUMS 2011 Males CADUMS 2012 Males CAS 2004 Females CADUMS 2008 Females CADUMS 2009 Females CADUMS 2010 Females CADUMS 2011 Females CADUMS 2012 Females
= 5,721 6,583 5,260 5,980 4,247 4,386 8,188 10,057 7,822 7,635 5,829 6,704
Cannabis use
Cannabis - lifetime 50.1 49.3 48.0 48.8 45.5 47.9 39.2 38.8 37.2 34.5 33.6 35.5
Cannabis - past-year 18.2 14.4 14.2 14.6 12.2 13.7 10.2 8.6 7.2 7.1 6.2 7.0
Cannabis - Age of initiation (years) 18.8 18.5 18.7 18.4 18.6 18.5 18.7 18.4 18.7 18.4 19.0 18.8
Illicit drug use past year
Cocaine/Crack 2.7 2.3 1.5 1.0 1.4 1.5 1.1 0.9 0.9 0.4
Speed 1.0 1.3 0.5 0.7 0.8 0.4
Hallucinogens (excl. salvia) 1.0 0.7 1.3 0.9 1.5 0.8 0.5
Hallucinogens (incl. salvia) 3.3 1.1 1.6 1.3 1.8 1.1 0.8 0.6
Ecstasy 1.5 1.7 1.1 0.9 0.9 0.7 1.1 0.7 0.6
Any 6 drugs (hallucinogens excl. salvia) 18.7 14.7 15.0 12.4 14.3 10.6 7.6 7.3 6.5 7.1
Any 5 drugs (hallucinogens excl. salvia) 4.3 2.5 2.5 2.4 2.9 1.8 1.5 1.2 1.0 1.0
Any 6 drugs (hallucinogens incl. salvia) 15.3 14.8 15.1 12.5 14.3 9.1 7.6 7.3 6.5 7.1
Any 5 drugs (hallucinogens incl. salvia) 5.5 2.8 2.8 2.7 3.1 2.4 1.5 1.3 1.1 1.1
Pharmaceutical use past year
Pain Relievers 18.9 18.3 20.9 15.8 15.5 24.2 20.2 20.3 17.4 18.2
Pain relievers to get high 0.3 0.5 0.4 0.4
Pain relievers to get high - among users 1.5 2.8 1.5 1.8
Abuse of pain relievers (includes to get high) 1.1 0.7
Abuse of pain relievers (includes to get high) - among users 6.9 3.9
Stimulants 1.0 0.6 1.2 1.2 1.9 1.2 1.2 0.9 0.5 1.1
Stimulants to get high 0.2 0.3
Stimulants to get high - among users 22.5 27.8
Abuse of stimulants (includes to get high) 0.6
Abuse of stimulants (includes to get high) - among users 32.5 52.2
Sedatives 8.0 7.0 6.4 5.9 7.5 13.2 11.1 10.8 12.0 12.8
Sedatives to get high 0.1 0.2
Sedatives to get high - among users 1.6
Any pharmaceutical 24.4 22.3 24.7 20.2 21.3 32.1 27.6 27.1 25.5 26.7
Any pharmaceutical to get high 0.5 0.7 1.2 0.6 0.4
Any pharmaceutical to get high - among users 2.1 3.3 5.6 1.9 1.5
Abuse of any pharmaceutical (includes to get high) 0.6 1.6 1.4
Abuse of any pharmaceutical (includes to get high) - among users 3.1 7.8 5.2
Drug related harms in past yearTable 5 footnote 1
Any drug harm to self - total population 3.8 3.5 2.7 2.3 3.0 1.9 1.8 1.7 1.3 1.1
Any drug harm to self among users any 5 drugsTable 5 footnote 2 37.2 36.1 35.8 38.2 41.7 35.7 40.7 37.5 49.7
Any drug harm to self among users any drugTable 5 footnote 3 18.4 22.8 15.8 16.6 18.3 16.0 19.8 19.2 19.3 13.3
  • Sample size
  • Estimate qualified due to high sampling variability; interpret with caution
  • Estimate suppressed due to high sampling variability
  • No comparable estimates.
  • Indicates the difference between 2008 and 2004 is statistically significant.
  • Indicates the difference between 2009 and 2004 is statistically significant.
  • Indicates the difference between 2010 and 2004 is statistically significant.
  • Indicates the difference between 2011 and 2004 is statistically significant.
  • Indicates the difference between 2012 and 2004 is statistically significant.
  • Indicates the difference between 2009 and 2008 is statistically significant.
  • Indicates the difference between 2010 and 2009 is statistically significant.
  • Indicates the difference between 2011 and 2010 is statistically significant.
  • Indicates the difference between 2012 and 2011 is statistically significant.
  • Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cocaine/crack, speed, ecstasy, hallucinogens, heroin
Table 5 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to table 5 footnote 1 referrer

Table 5 footnote 2

Among past year users any 5 drugs (cocaine, speed, hallucinogens, ecstasy, heroin). CADUMS 2010-2012: hallucinogens include salvia.

Return to table 5 footnote 2 referrer

Table 5 footnote 3

Among past year users CAS (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, steroids), CADUMS 2008 (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2010 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2011-2012 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, abuse of pain killers, abuse of stimulants, sedatives to get high)

Return to table 5 footnote 3 referrer

Table 6: Main 2012 CADUMS indicators by sex and by age - Alcohol
  Overall Males Females p<0.05
- sex
15-24 25+ p<0.05
- age
= 11,090 4,386 6,704   687 10,403  
Alcohol
Lifetime Use 91.0
[89.9-92.2]
92.9
[91.2-94.5]
89.3
[87.6-90.9]
79.5
[74.7-84.3]
93.1
[92.1-94.1]
Past 12 month Use 78.4
[77.0-79.9]
82.7
[80.6-84.8]
74.4
[72.4-76.4]
70.0
[64.5-75.5]
80.0
[78.6-81.4]
Past 30 days Use 63.3
[61.6-65.1]
69.8
[67.1-72.4]
57.2
[55.0-59.5]
49.9
[44.1-55.7]
65.8
[64.1-67.6]
Age of initiation (years) 18.3
[18.1-18.5]
17.3
[17.1-17.6]
19.2
[19.0-19.5]
16.2
[16.0-16.5]
18.6
[18.4-18.8]
Exceeding low-risk drinking guidelines (LRDG)Table 6 footnote 1
Exceeds LRDG chronic 14.4
[13.1-15.7]
17.3
[15.1-19.5]
11.8
[10.2-13.3]
17.0
[12.5-21.5]
13.9
[12.6-15.2]
 
Exceeds LRDG acute 9.9
[8.8-11.0]
12.9
[11.1-14.8]
7.2
[6.0-8.4]
12.5
[8.5-16.4]
9.4
[8.4-10.5]
 
Exceeds LRDG chronic - among drinkers 18.6
[16.9-20.2]
21.2
[18.5-23.8]
15.9
[13.9-17.9]
24.4
[18.3-30.6]
17.6
[15.9-19.2]
Exceeds LRDG acute - among drinkers 12.8
[11.4-14.2]
15.8
[13.5-18.0]
9.7
[8.1-11.4]
17.9
[12.4-23.3]
11.9
[10.6-13.3]
  • [95% Confidence Interval]
  • Sample size
  • Significant difference between males and females
  • Significant difference between youth age 15-24 and adults age 25+
Table 6 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 6 footnote 1 referrer

Table 7: Main 2012 CADUMS indicators by province - Alcohol
  Canada NL PE NS NB QC ON MB SK AB BC
= 11,090 1,008 1,008 1,009 1,009 1,008 1,011 1,009 1,010 1,009 2,009
Alcohol
Lifetime Use 91.0 91.2 89.6 90.8 92.0 92.8 90.1 92.8 93.6 88.3 91.4
Past 12 month Use 78.4 76.0 74.0 72.3 73.8 82.1 77.7 79.5 78.5 76.2 78.1
Past 30 days Use 63.3 58.5 56.8 53.1 56.7 68.0 63.1 62.8 62.7 59.4 62.9
Exceeding low-risk drinking guidelines (LRDG)Table 7 footnote 1
Exceeds LRDG chronic 14.4 16.1 12.3 13.0 15.0 16.1 14.5 13.6 14.6 11.9 13.5
Exceeds LRDG acute 9.9 13.4 9.2 10.1 10.4 10.4 9.9 8.6 11.3 8.8 9.9
Exceeds LRDG chronic - among drinkers 18.6 21.5 16.9 18.3 20.5 19.9 18.8 17.3 18.8 15.8 17.6
Exceeds LRDG acute - among drinkers 12.8 17.9 12.7 14.2 14.2 12.8 12.8 10.9 14.5 11.6 12.8

Sample size

Table 7 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 7 footnote 1 referrer

Table 8: Prevalence of alcohol use and exceeding LRDG, total population, CAS 2004, CADUMS 2008 - 2012
  2004 Overall 2008 Overall 2009 Overall 2010 Overall 2011 Overall 2012 Overall
= 13,909 16,640 13,082 13,615 10,076 11,090
Alcohol
Lifetime Use 92.8
[91.6-93.9]
90.2
[89.2-91.1]
88.6
[87.5-89.6]
88.9
[87.9-89.9]
89.7
[88.4-91.0]
91.0
[89.9-92.2]
Past 12 month Use 79.3
[78.1-80.5]
77.3
[76.0-78.6]
76.5
[75.1-77.8]
77.0
[75.6-78.3]
78.0
[76.4-79.5]
78.4
[77.0-79.9]
Age of initiation (years) 17.9
[17.8-18.1]
18.0
[17.9-18.2]
18.0
[17.9-18.2]
18.2
[18.0-18.3]
18.1
[18.0-18.3]
18.3
[18.1-18.5]
Exceeding low-risk drinking guidelinesTable 8 footnote 1
Exceeds LRDG chronic 14.3
[13.2-15.3]
15.0
[13.9-16.2]
14.5
[13.3-15.7]
14.5
[13.4-15.6]
14.4
[13.1-15.8]
14.4
[13.1-15.7]
Exceeds LRDG acute 10.2
[9.2-11.1]
10.9
[9.8-11.9]
11.7
[10.5-12.9]
10.5
[9.5-11.5]
10.1
[8.9-11.2]
9.9
[8.8-11.0]
Exceeds LRDG chronic - among drinkers 18.0
[16.7-19.4]
19.8
[18.3-21.2]
19.1
[17.6-20.7]
19.1
[17.6-20.5]
18.7
[17.0-20.4]
18.6
[16.9-20.2]
Exceeds LRDG acute - among drinkers 12.9
[11.7-14.0]
14.3
[12.9-15.6]
15.5
[14.0-17.0]
13.8
[12.6-15.1]
13.1
[11.6-14.5]
12.8
[11.4-14.2]
  • [95% Confidence Interval]
  • Sample size
  • Indicates the difference between 2008 and 2004 is statistically significant.
  • Indicates the difference between 2009 and 2004 is statistically significant.
  • Indicates the difference between 2010 and 2004 is statistically significant.
  • Indicates the difference between 2011 and 2004 is statistically significant.
Table 8 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 8 footnote 1 referrer

Table 9: Prevalence of alcohol use and Exceeding LRDG, by age, CAS 2004, CADUMS 2008 - 2012
  CAS
2004
15-24
CADUMS 2008
15-24
CADUMS 2009
15-24
CADUMS 2010
15-24
CADUMS 2011
15-24
CADUMS 2012
15-24
CAS 2004
25+
CADUMS 2008
25+
CADUMS 2009
25+
CADUMS 2010
25+
CADUMS 2011
25+
CADUMS 2012
25+
= 2,085 1,443 955 3,989 671 687 11,519 15,197 12,079 9,626 9,405 10,403
Alcohol
Lifetime Use 90.0 83.5 81.8 79.0 77.9 79.5 93.6 91.4 89.9 90.9 92.0 93.1
Past 12 month Use 82.9 78.4 75.5 71.5 70.8 70.0 78.8 77.1 76.7 78.0 79.3 80.0
Age of initiation (years) 15.6 15.6 15.9 15.9 16.0 16.2 18.3 18.5 18.4 18.6 18.5 18.6
Exceeding low-risk drinking guidelinesTable 9 footnote 1
Exceeds LRDG chronic 18.6 22.8 19.8 18.4 14.9 17.0 9.8 13.6 13.4 13.8 14.4 13.9
Exceeds LRDG acute 13.7 18.4 17.4 15.1 12.8 12.5 6.4 9.4 10.6 9.6 9.5 9.4
Exceeds LRDG chronic - among drinkers 22.4 29.5 26.4 25.9 21.1 24.4 13.0 17.9 17.7 17.8 18.3 17.6
Exceeds LRDG acute - among drinkers 16.5 23.8 23.2 21.3 18.1 17.9 8.6 12.4 13.9 12.5 12.2 11.9
  • Sample size
  • Indicates the difference between 2009 and 2004 is statistically significant.
  • Indicates the difference between 2011 and 2004 is statistically significant.
  • Indicates the difference between 2012 and 2004 is statistically significant.
Table 9 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 9 footnote 1 referrer

Table 10: Prevalence of alcohol use and exceeding LRDG, by sex, CAS 2004, CADUMS 2008 - 2012
  CAS
2004
Males
CADUMS 2008
Males
CADUMS 2009
Males
CADUMS 2010
Males
CADUMS 2011
Males
CADUMS 2012
Males
CAS 2004
Females
CADUMS 2008
Females
CADUMS 2009
Females
CADUMS 2010
Females
CADUMS 2011
Females
CADUMS 2012
Females
= 5,721 6,583 5,260 5,980 4,247 4,386 8,188 10,057 7,822 7,635 5,829 6,704
Alcohol
Lifetime Use 94.6 93.0 91.0 91.3 92.9 92.9 91.1 87.5 86.3 86.7 86.8 89.3
Past 12 month Use 82.0 81.4 80.2 80.2 81.9 82.7 76.8 73.5 73.0 73.9 74.3 74.4
Age of initiation (years) 17.1 17.4 17.3 17.5 17.5 17.3 18.7 18.6 18.7 18.8 18.8 19.2
Exceeding low-risk drinking guidelinesTable #t10_fnb10 footnote 1
Exceeds LRDG chronic 17.2 18.9 17.6 17.2 18.1 17.3 11.5 11.6 11.6 12.1 11.1 11.8
Exceeds LRDG acute 13.0 14.8 15.2 13.6 13.5 12.9 7.5 7.4 8.5 7.7 7.0 7.2
Exceeds LRDG chronic - among drinkers 21.1 23.6 22.2 21.8 22.3 21.2 15.0 16.0 22.2 16.4 15.0 15.9
Exceeds LRDG acute - among drinkers 15.9 18.5 19.1 17.1 16.6 15.8 9.8 10.1 11.8 10.5 9.5 9.7
  • Sample size
  • Indicates the difference between 2008 and 2004 is statistically significant.
  • Indicates the difference between 2009 and 2004 is statistically significant.
  • Indicates the difference between 2010 and 2004 is statistically significant.
  • Indicates the difference between 2011 and 2004 is statistically significant.
  • Indicates the difference between 2012 and 2011 is statistically significant.
Table 10 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 10 footnote 1 referrer

Page details

Date modified: